Alvotech (ALVO) Receivables - Other (2020 - 2026)
Alvotech's (ALVO) quarterly Receivables - Other came in at $165.0 million in Q2 2026, up 414.52% on a YoY basis from $32.1 million in Q2 2025, and up 26.9% quarter-over-quarter from $130.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Receivables - Other (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Receivables - Other for 7 consecutive years, with $165.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Other rose 414.52% year-over-year to $165.0 million; the trailing twelve-month figure through Jun 2026 stood at $165.0 million (up 414.52% YoY), and the FY2025 full-year result was $122.9 million, up 441.32% from the prior year.
- Receivables - Other improved to $165.0 million in Q2 2026 per ALVO's latest filing, from $130.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $165.0 million in Q2 2026 and bottomed at $3.3 million in Q4 2022.
- Historically, Receivables - Other has averaged $47.4 million across 5 years, with a median of $25.8 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Receivables - Other slumped 43.98% in 2023, then soared 472.58% in 2026.
- Over 5 years, Receivables - Other stood at $3.3 million in 2022, then jumped by 230.37% to $10.9 million in 2023, then soared by 109.19% to $22.7 million in 2024, then soared by 441.32% to $122.9 million in 2025, then jumped by 34.22% to $165.0 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $165.0 million, $130.0 million, and $122.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.01 Mn |
| Mar 31, 2026 | 130.03 Mn |
| Dec 31, 2025 | 122.93 Mn |
| Sep 30, 2025 | 58.70 Mn |
| Jun 30, 2025 | 32.07 Mn |
| Mar 31, 2025 | 22.71 Mn |
| Dec 31, 2024 | 22.71 Mn |
| Sep 30, 2024 | 28.83 Mn |
| Jun 30, 2024 | 33.46 Mn |
| Mar 31, 2024 | 10.36 Mn |
| Dec 31, 2023 | 10.86 Mn |
| Jun 30, 2023 | 8.31 Mn |
| Dec 31, 2022 | 3.29 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Dec 31, 2020 | 2.19 Mn |